Unveiling the Diversity of Fibroblasts in Skin Cancer

**MedUni Vienna's Department of Dermatology** has conducted a pioneering study on the diversity of cancer-associated fibroblasts (CAFs) in skin cancer. These specialized cells contribute significantly to the tumor environment through their diverse immunomodulatory roles. By dissecting the molecular and spatial characteristics of fibroblasts in basal cell carcinoma, squamous cell carcinoma, and melanoma, researchers identified three distinct CAF subtypes: myofibroblast-like RGS5+ CAFs, matrix CAFs (mCAFs), and immunomodulatory CAFs (iCAFs). The study highlights the adaptive distribution of these subtypes, particularly noting that aggressive forms of cancer show increased iCAF presence. This subtype produces signaling molecules, attracting and activating immune cells, and may hold the key to innovative treatments by modulating the immune response. Principal investigator Beate Lichtenberger suggests targeting these CAF subtypes could improve therapeutic outcomes, emphasizing the potential for developing effective, immune-based skin cancer treatments.